The diagnostic value of different laboratory methods in detecting Chlamydia trachomatis infections in high risk groups was analysed. The efficiency of a direct specimen test was compared with serology ...

Point-of-care testing for common sexually transmitted infections may reduce overuse of antibiotics and improve emergency ...

Chlamydia trachomatis infections are a global health problem. This obligate intracellular bacterial pathogen comprises lymphogranuloma venereum (L1–L3), ocular (A–C) and genital (D–K) serovars.

Chlamydia trachomatis remains a major global pathogen causing both ocular and genital infections, contributing significantly to public health burdens such as infertility, pelvic inflammatory disease, ...

A new variant of Chlamydia trachomatis (nvCT) was discovered in Sweden in 2006, and it could not be detected by diagnostic systems from Abbott and Roche, whereas the third system used, from Becton ...

A 50-year-old mystery surrounding the existence of a cell wall in the bacterial pathogen Chlamydia trachomatis, or chlamydia, has been solved. Chlamydia is the leading cause of sexually transmitted ...

The obligate bacterium, Chlamydia trachomatis, is an insidious microorganism that causes the sexually-transmitted disease, Chlamydia, in humans. Infections are progressive, with undiagnosed patients ...

When Chlamydia attacks the human body the immune system starts its defense mechanisms. But the bacteria find a way to defend themselves. Scientists have deciphered new details of their strategy now.

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA) has ...

Chlamydia is a prevalent sexually transmitted infection. World Health Organisation reports millions of new STI cases annually. Chlamydia trachomatis is a common cause. Many infected individuals show ...